XBRL SEC Pilot Pfizer Inc.

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KCYwceMDCCZMIWuwea1EliKF7yeT4kk40CCgBqkyzbapuwgWbW5aL2x14FqzDmXi aYqSb/UHH3QA4r8Dlkuhpg== 0000078003-06-000317.txt : 20061130 0000078003-06-000317.hdr.sgml : 20061130 20061130124124 ACCESSION NUMBER: 0000078003-06-000317 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20061130 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20061130 DATE AS OF CHANGE: 20061130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 061247534 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 8-K 1 k8pfe-20060402.htm XBRL PFIZER 8-K XBRL SEC Pilot Pfizer Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: November 30, 2006 Date of earliest event reported: November 30, 2006
PFIZER INC. (Exact name of registrant as specified in its charter)

DELAWARE (State or other jurisdiction of incorporation)	1-3619 (Commission File Number)	13-5315170 (I.R.S. Employer Identification No.)

235 East 42nd Street, New York, New York 10017 (Address of principal executive offices) (zip code) (212) 573-2323 (Registrant's telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events

Exhibit 100 to this Current Report on Form 8-K contains documents formatted in XBRL (eXtensible Business Reporting Language) with information from Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter ended April 2, 2006, filed with the Securities and Exchange Commission (SEC) on May 8, 2006. The information formatted in XBRL includes the (i) Condensed Consolidated Statements of Income for the three months ended April 2, 2006 and April 3, 2005, (ii) Condensed Consolidated Balance Sheets at April 2, 2006 and December 31, 2005, and (iii) Condensed Consolidated Statements of Cash Flows for the three months ended April 2, 2006 and April 3, 2005.

Users of this data are advised pursuant to Rule 401 of Regulation S-T that the financial information contained in the XBRL-Related Documents is unaudited and these are not the official financial statements of Pfizer Inc. as filed with the SEC. The purpose of furnishing these XBRL formatted documents is solely for the purpose of participation in the SEC's voluntary XBRL pilot program to test the related format and technology and, as a result, investors should continue to rely on the official filed version of the furnished documents and not rely on the information in this Current Report on Form 8-K, including Exhibit 100, in making investment decisions.

In accordance with Rule 402 of Regulation S-T, the information in this Current Report on Form 8-K, including Exhibit 100, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d)	Exhibits

	The following exhibits are furnished herewith:

	Exhibit Number	Exhibit Description

	100	The following financial statements from Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter ended April 2, 2006, filed on May 8, 2006, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Income for the three months ended April 2, 2006 and April 3, 2005, (ii) the Condensed Consolidated Balance Sheets at April 2, 2006 and December 31, 2005, and (iii) the Condensed Consolidated Statements of Cash Flows for the three months ended April 2, 2006 and April 3, 2005.

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.


		PFIZER INC.

		By: /s/ Margaret M. Foran
		Margaret M. Foran


Dated: November 30, 2006		Title: Senior Vice President-Corporate Governance
		Associate General Counsel and Corporate Secretary

EXHIBIT INDEX

Exhibit No.		Description

EX-100.INS		XBRL Instance Document

EX-100.SCH		XBRL Taxonomy Extension Schema Document

EX-100.SCH.1		XBRL Schema Supplement Document

EX-100.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

EX-100.LAB		XBRL Taxonomy Extension Label Linkbase Document

EX-100.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

EX-100.INS 2 pfe-20060402.xml XBRL INSTANCE DOCUMENT 0000078003 2005-04-03 unaudited 0000078003 2004-12-31 audited 0000078003 2006-01-01 2006-04-02 unaudited 0000078003 2005-01-01 2005-04-03 unaudited 0000078003 2006-04-02 unaudited 0000078003 2005-12-31 audited xbrli:shares iso4217:USD xbrli:shares iso4217:USD 1675000000 1504000000 882000000 828000000 0.19 0.24 -237000000 -903000000 29000000 3000000 0 0 0 0 1772000000 5000000 -923000000 -729000000 -4000000 -76000000 -65000000 -5000000 41000000 3000000 272000000 4108000000 -12000000 0 557000000 640000000 1591000000 826000000 1213000000 0 2000000 2000000 2497000000 2543000000 18000000 0 3000000 4000000 4522000000 4084000000 7522000000 7717000000 -4000000 0 1038000000 -272000000 149000000 -177000000 2651000000 2718000000 3196000000 4302000000 -465000000 -418000000 219000000 306000000 11589000000 5059000000 510000000 445000000 115000000 173000000

9765000000

10352000000

2226000000

1892000000

479000000

851000000

-1440000000

67759000000

67931000000

117565000000

112959000000

160000000

151000000

0.04

0.56

1808000000

1476000000

2247000000

2869000000

141000000

213000000

439000000

2191000000

1973000000

28403000000

19674000000

483000000

-714000000

10240000000

10337000000

0.04

0.56

-1400000000

-1743000000

-2000000

-4000000

22000000

172000000

2910000000

4427000000

0.04

0.56

0.04

0.56

3617000000

3495000000

27786000000

28073000000

23774000000

23741000000

6039000000

6663000000

51801000000

43350000000

117565000000

112959000000

6347000000

6508000000

-818000000

-8766000000

-2705000000

5431000000

3193000000

3961000000

301000000

4111000000

-332000000

622000000

98000000

25000000

13091000000

12660000000

1443000000

1448000000

-919000000

-1000000000

2717000000

2665000000

169000000

159000000

1000000

1035000000

93000000

7000000

5000000

3000000

2531000000

10438000000

2000000

17090000000

17103000000

2635000000

315000000

-494000000

-216000000

-70000000

-35000000

-4891000000

-2735000000

-1000000

-205000000

-8056000000

1764000000

1588000000

37608000000

41715000000

437000000

4000000

4085000000

3810000000

19979000000

12633000000

65764000000

69609000000

41896000000

37415000000

1366000000

1351000000

-39767000000

-40757000000

7474000000

7324000000

7416000000

7314000000

2000000

(a) Exclusive of amortization of intangible assets, except as disclosed in Note11B, Goodwill and Other Intangible Assets: Other Intangible Assets. EX-100.SCH 3 pfe-20060402.xsd XBRL EXTENSION TAXONOMY EX-100.SCH.1 4 pfe-ssu_xbrl.xsd XBRL SCHEMA SUPPLEMENT DOCUMENT EX-100.CAL 5 pfe-20060402_cal.xml XBRL CALCULATION LINKBASE EX-100.LAB 6 pfe-20060402_lab.xml XBRL LABEL LINKBASE Cost of sales Selling, informational and administrative expenses Other assets (including deposits and advances) deferred taxes and deferred charges Other assets, deferred taxes and deferred charges Prepaid Expenses - Total Prepaid Insurance Dividends payable represent dividends declared but not yet paid. Dividends payable Liabilities Discontinued Operations - Current Postretirement benefit obligations Accrued compensation and related items includes accrued employee compensation, accrued payroll taxes, accrued pension, accrued postemployment benefits, accrued postretirement benefits and other related items Accrued compensation and related items Consists of deferred tax liability-current and other current liabilites Other current liabilities Represents the fair value of Pfizer Inc shares owned by the Trust used to fund Pfizer's employee benefit plans. Employee benefit trust, at fair value Income from continuing operations before provision for taxes on income and minority interests Loss from discontinued operations-net of tax Income (loss) of a business segment that has been discontinued net of taxes Income/(Loss) from Disposition of Discontinued Operations - Total Cash dividends paid per common share cash dividends paid per common share Restructuring charges are associated with the exit or disposal of an activity, including one-time termination benefits, contract termination costs and other exit costs (e.g., consolidation of facilities). Merger-related costs consist of integration costs directly related to acquisitions and restructuring costs incurred in connection with acquisitions. Restructuring charges and merger-related costs Includes other current liabilities and deferred income taxes payable current Other current liabilities Consists of other current liabilities and deferred income tax liabilities current. Other current liabilities Other (income)/deductions-net Other (income)/deductions-net can include non operating items such as interest income/expense, royalty income, asset impairments, gains/losses on sale of fixed assets, gains/losses on disposals of investments or products. income from continuing operations after provision for taxes and minority interest Income from continuing operations Net cash provided by continuing operating activities cash payments for purchases of property, plant and equipment Purchases of property, plant and equipment Proceeds from redemptions of short-term investments Proceeds from sales of long-term investments Purchases of long-term investments Acquisitions, net of cash acquired Net cash provided by/(used in) investing activities Cash provided by/(used in) other investing activities, net. Other investing activities Share-based compensation expense Merger-related in-process research and development charges Asset impairment charge Other non-cash adjustments Deferred taxes from continuing operations Proceeds from the sales of businesses, product lines and other products Increase in short-term borrowings, net Principal payments on short-term borrowings Proceeds from issuances of long-term debt Principal payments on long-term debt Purchases of common stock Cash dividends paid cash received from stock option exercises and other financing related cash transactions not previously identified Stock option transactions and other Net cash used in financing activities Effect of exchange-rate changes on cash and cash equivalents Cash and cash equivalents at beginning of period cash paid for income taxes Cash paid during the period for income taxes Cash paid during the period for interest amortization of intangible assets Amortization of intangible assets subsidiary income not owned by the consolidating entity, net of taxes Minority interests Revenues Research and development expenses Merger-related in-process research and development charges Provision for taxes on income Income/(Loss) from Disposition of Discontinued Operations Gain on disposal of discontinued operations net of tax Gains on sales of discontinued operations - net of tax Income from continuing operations per common share-basic Income/(Loss) from Discontinued Operations per Outstanding Share Net income per common share-basic Weighted-average shares used to calculate earnings per common share-basic Income/(loss) from Disposition of Discontinued Operations per Outstanding Share Net income per common share-diluted Weighted-average shares used to calculate earnings per common share-diluted Income from continuing operations per common share-diluted Cash and cash equivalents Accounts receivable, less allowance for doubtful accounts Short-term investments Inventories Assets Discontinued Operations-Current Total current assets Property, plant and equipment, less accumulated depreciation Identifiable intangible assets, less accumulated amortization Total assets Accounts payable Income taxes payable Total current liabilities Long-term debt Pension benefit obligations Deferred taxes Other noncurrent liabilities Total liabilities Preferred stock Common stock Additional paid-in capital Treasury stock Retained earnings Accumulated other comprehensive income Total shareholders' equity Total liabilities and shareholders' equity Purchases of short-term investments Proceeds from sales of other assets Net increase/(decrease) in cash and cash equivalents Depreciation and amortization Purchases of other assets Cash and cash equivalents at end of period Income/(loss) from discontinued operations per common share basic Discontinued operations-net of tax per common share-basic Income/(loss) from discontinued operations per common share diluted Discontinued operations-net of tax per common share-diluted Assets held for sale Liabilities held for sale and anticipated to be sold within 12 months. Liabilities held for sale Net income Income/(Loss) from Discontinued Operations, Net of Tax Effect Total Long-term investments and loans consists of (a) investments in nonconsolidated subsidiaries accounted for using the equity and or cost method; (b) debt and equity financial instruments which can include trading securities, held-to-maturity and securities available for sale; (c) long-terms loans with maturities in excess of one year. The portion of long-term loans that is due to be collected within one year is recorded under Short-term loans. Long-term investments and loans Short term borrowings have maturities within 12 months, including portion of long-term debt with maturities within 12 months Short-term borrowings, including current portion of long-term debt Includes minority interest and other noncurrent liabilities. Other noncurrent liabilities The net of new short-term borrowings with maturities of 90 days or less and new repayments of short-term borrowings with maturities of 90 days or less, plus new short-term borrowings with maturities greater than 90 days Increase in short-term borrowings, net Non cash charges for intangible asset impairments and associated non-cash charges. Intangible asset impairments and other associated non-cash charges Gains on disposal of investments, products and product lines Gains on disposal of investments, products and product lines Loss from operations of a business segment that has been reported as discontinued operations. Loss from discontinued operations Change in operating assets and liabilities from beginning to end of period. Changes in assets and liabilities (net of businesses acquired and divested) Non-cash gains from sales of business segment that has been reported as discontinued operations. Gains on sales of discontinued operations Noncash deferred taxes related to discontinued operations Other deferred taxes Includes Prepaid expenses and current deferred tax asset. Prepaid expenses are the unamortized costs of rights to receive a service or use a resource. These prepayments include, for example, employee advances, prepaid insurance, prepaid taxes, etc. Prepaid expenses and taxes Short-term loans are those with an original maturity of one year or less. Also included in this account is the portion of long-term loans that are due to be collected within one year. Short-term loans Total of operations and gains/(losses) on sales of discontinued operations. Discontinued operations - net of tax EX-100.PRE 7 pfe-20060402_pre.xml XBRL PRESENTATION LINKBASE -----END PRIVACY-ENHANCED MESSAGE-----